Shinya Tanaka

Active 1992–2025

178
Papers
19,398
Citations
79
h-index
145
i10-index

Citations

Citations per year for Shinya Tanaka1984: 1 citations1993: 1 citations1994: 22 citations1995: 42 citations1996: 44 citations1997: 53 citations1998: 61 citations1999: 65 citations2000: 46 citations2001: 63 citations2002: 74 citations2003: 54 citations2004: 59 citations2005: 54 citations2006: 53 citations2007: 62 citations2008: 83 citations2009: 88 citations2010: 138 citations2011: 114 citations2012: 188 citations2013: 181 citations2014: 203 citations2015: 158 citations2016: 150 citations2017: 171 citations2018: 158 citations2019: 549 citations2020: 584 citations2021: 620 citations2022: 850 citations2023: 744 citations2024: 961 citations2025: 434 citations2026: 12 citations1985–1992: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,365 citing papers, 26.3% of this breakdownChina: 1,205 citing papers, 13.4% of this breakdownJapan: 900 citing papers, 10% of this breakdownUnited Kingdom: 500 citing papers, 5.6% of this breakdownGermany: 476 citing papers, 5.3% of this breakdownItaly: 280 citing papers, 3.1% of this breakdownCanada: 254 citing papers, 2.8% of this breakdownAustralia: 246 citing papers, 2.7% of this breakdownFrance: 240 citing papers, 2.7% of this breakdownNetherlands: 180 citing papers, 2% of this breakdownSpain: 157 citing papers, 1.7% of this breakdownIndia: 150 citing papers, 1.7% of this breakdown
0%26.3%Other 22.7%

Fields

  • Medicine52.4%
  • Biochemistry, Genetics and Molecular Biology20.6%
  • Immunology and Microbiology19.1%
  • Neuroscience2.2%
  • Computer Science1.8%
  • Engineering0.8%
  • Other3.1%

Topics

  • Immune Cell Function and Interaction6%
  • T-cell and B-cell Immunology5%
  • SARS-CoV-2 and COVID-19 Research4.1%
  • Immunotherapy and Immune Responses2.7%
  • CAR-T cell therapy research2.5%
  • COVID-19 Clinical Research Studies1.9%
  • Other77.8%

Coauthors

All papers

Open in search
  1. A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects

    Authors: , , , , , , , , - Nature Medicine 2018 cited by 600

  2. Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Miki Iida, Keiko Kasahara, Koshiro Tabata, Mariko Ishizuka, Asako Shigeno, Kenzo Tokunaga, Seiya Ozono, Isao Yoshida, So Nakagawa, Jiaqi Wu, Miyoko Takahashi, Atsushi Kaneda, M. Seki, Ryoji Fujiki, Bahityar Rahmutulla Nawai, Yutaka Suzuki, Yukie Kashima, Kazumi Abe, Kiyomi Imamura, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Kayoko Nagata, Yugo Kawai, Yohei Yanagida, Yusuke Tashiro, Otowa Takahashi, Kazuko Kitazato, Haruyo Hasebe, Chihiro Motozono, Mako Toyoda, Toong Seng Tan, Isaac Ngare, Takamasa Ueno, Akatsuki Saito, Erika P. Butlertanaka, Yuri Tanaka, Nanami Morizako, Hirofumi Sawa, Terumasa Ikeda, Takashi Irie, Keita Matsuno, Shinya Tanaka, Takasuke Fukuhara, Kei Sato - Nature 2022 cited by 754

  3. Virological characteristics of the SARS-CoV-2 XBB variant derived from recombination of two Omicron subvariants

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Sadamasu, Kazuhisa Yoshimura, Yuki Yamamoto, Tetsuharu Nagamoto, Gideon Schreiber, Katsumi Maenaka, Hayato Ito, Naoko Misawa, Izumi Kimura, Mai Suganami, Mika Chiba, Ryo Yoshimura, Kyoko Yasuda, Keiko Iida, Naomi Ohsumi, Adam Strange, Otowa Takahashi, Kimiko Ichihara, Yuki Shibatani, Tomoko Nishiuchi, Marie Kato, Zannatul Ferdous, Hiromi Mouri, Kenji Shishido, Hirofumi Sawa, Rina Hashimoto, Yukio Watanabe, Ayaka Sakamoto, Naoko Yasuhara, Tateki Suzuki, Kanako Kimura, Yukari Nakajima, So Nakagawa, Jiaqi Wu, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Kayoko Nagata, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Yugo Kawai, Takashi Irie, Ryoko Kawabata, Chihiro Motozono, Mako Toyoda, Takamasa Ueno, Takao Hashiguchi, Terumasa Ikeda, Takasuke Fukuhara, Akatsuki Saito, Shinya Tanaka, Keita Matsuno, Kazuo Takayama, Kei Sato - Nature Communications 2023 cited by 347

  4. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Kazuhisa Yoshimura, Akifumi Takaori‐Kondo, Masaki Imai, Mika Chiba, Hirotake Furihata, Haruyo Hasebe, Kazuko Kitazato, Haruko Kubo, Naoko Misawa, Nanami Morizako, Kohei Noda, Akiko Oide, Mai Suganami, Miyoko Takahashi, Kana Tsushima, Miyabishara Yokoyama, Yue Yuan, Shinya Tanaka, So Nakagawa, Terumasa Ikeda, Takasuke Fukuhara, Yoshihiro Kawaoka, Kei Sato - Nature 2021 cited by 689

  5. Follicular regulatory T cells expressing Foxp3 and Bcl-6 suppress germinal center reactions

    Authors: , , , , , , , , , , , , , - Nature Medicine 2011 cited by 1,096

  6. Bcl6 Mediates the Development of T Follicular Helper Cells

    Authors: , , , , , , , - Science 2009 cited by 1,499

  7. Characterization and Function of Tumor Necrosis Factor and Interleukin‐6–Induced Osteoclasts in Rheumatoid Arthritis

    Authors: , , , , , , , , , - Arthritis & Rheumatology 2021 cited by 221

  8. Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gideon Schreiber, Saori Suzuki, Marie Kato, Zannatul Ferdous, Hiromi Mouri, Kenji Shishido, Naoko Misawa, Izumi Kimura, Yusuke Kosugi, Pan Lin, Mai Suganami, Mika Chiba, Ryo Yoshimura, Kyoko Yasuda, Keiko Iida, Naomi Ohsumi, Adam Strange, Daniel Sauter, So Nakagawa, Jiaqi Wu, Yukio Watanabe, Ayaka Sakamoto, Naoko Yasuhara, Yukari Nakajima, Hisano Yajima, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Kayoko Nagata, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Y. Kawa, Takashi Irie, Ryoko Kawabata, Ryo Shimizu, Otowa Takahashi, Kimiko Ichihara, Chihiro Motozono, Mako Toyoda, Takamasa Ueno, Yuki Shibatani, Tomoko Nishiuchi, Akatsuki Saito, Keita Matsuno, Kazuo Takayama, Takao Hashiguchi, Shinya Tanaka, Takasuke Fukuhara, Terumasa Ikeda, Kei Sato - Nature Communications 2023 cited by 157

  9. Virological characteristics of the SARS-CoV-2 Omicron BA.2 spike

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jin Kuramochi, M. Seki, Ryoji Fujiki, Atsushi Kaneda, Tadanaga Shimada, Taka‐aki Nakada, Seiichiro Sakao, Takuji Suzuki, Takamasa Ueno, Akifumi Takaori‐Kondo, Ken J. Ishii, Gideon Schreiber, Hirofumi Sawa, Akatsuki Saito, Takashi Irie, Shinya Tanaka, Keita Matsuno, Takasuke Fukuhara, Terumasa Ikeda, Kei Sato - Cell 2022 cited by 352

  10. Virological characteristics of the SARS-CoV-2 Omicron BA.2 subvariants, including BA.4 and BA.5

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kenji Sadamasu, Kazuhisa Yoshimura, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Jin Kuramochi, Gideon Schreiber, Ken J. Ishii, Takao Hashiguchi, Terumasa Ikeda, Akatsuki Saito, Takasuke Fukuhara, Shinya Tanaka, Keita Matsuno, Kei Sato - Cell 2022 cited by 297

  11. Virological characteristics of the SARS-CoV-2 Omicron BA.2.75 variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yuki Yamamoto, Tetsuharu Nagamoto, Hiroyuki Asakura, Mami Nagashima, Kenji Sadamasu, Kazuhisa Yoshimura, Takamasa Ueno, Gideon Schreiber, Akifumi Takaori‐Kondo, Kotaro Shirakawa, Hirofumi Sawa, Takashi Irie, Takao Hashiguchi, Kazuo Takayama, Keita Matsuno, Shinya Tanaka, Terumasa Ikeda, Takasuke Fukuhara, Kei Sato - Cell Host & Microbe 2022 cited by 172

  12. Virological characteristics of the SARS-CoV-2 BA.2.86 variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jiří Zahradník, Terumasa Ikeda, Kazuo Takayama, Keita Matsuno, Takasuke Fukuhara, Kei Sato - Cell Host & Microbe 2024 cited by 99

  13. Empagliflozin suppresses mitochondrial reactive oxygen species generation and mitigates the inducibility of atrial fibrillation in diabetic rats

    Authors: , , , , , , , , , , , , , , , , - Frontiers in Cardiovascular Medicine 2023 cited by 58

  14. Characteristics of the SARS-CoV-2 omicron HK.3 variant harbouring the FLip substitution

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hayato Ito, Keita Matsuno, Hirofumi Sawa, Naganori Nao, Shinya Tanaka, Masumi Tsuda, Lei Wang, Yoshikata Oda, Zannatul Ferdous, Kenji Shishido, So Nakagawa, Kotaro Shirakawa, Akifumi Takaori‐Kondo, Kayoko Nagata, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Yugo Kawai, Kazuo Takayama, Rina Hashimoto, Sayaka Deguchi, Yukio Watanabe, Ayaka Sakamoto, Naoko Yasuhara, Takao Hashiguchi, Tateki Suzuki, Kanako Kimura, Jiei Sasaki, Yukari Nakajima, Hisano Yajima, Takashi Irie, Ryoko Kawabata, Kaori Tabata, Terumasa Ikeda, Hesham Nasser, Ryo Shimizu, MST Monira Begum, Michael Jonathan, Yuka Mugita, Otowa Takahashi, Kimiko Ichihara, Takamasa Ueno, Chihiro Motozono, Mako Toyoda, Akatsuki Saito, Maya Shofa, Yuki Shibatani, Tomoko Nishiuchi, Kei Sato - The Lancet Microbe 2024 cited by 45

  15. The Methylcytosine Dioxygenase Tet2 Promotes DNA Demethylation and Activation of Cytokine Gene Expression in T Cells

    Authors: , , , , , , , , , , , , , - Immunity 2015 cited by 323

  16. Virological characteristics of the SARS-CoV-2 Omicron XBB.1.5 variant

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ryoko Kawabata, Yukio Watanabe, Ayaka Sakamoto, Naoko Yasuhara, Tateki Suzuki, Yukari Nakajima, Zannatul Ferdous, Kenji Shishido, Yuka Mugita, Otowa Takahashi, Kimiko Ichihara, Yu Kaku, Naoko Misawa, Ziyi Guo, Alfredo A. Hinay, Yusuke Kosugi, Shigeru Fujita, Jarel M. Tolentino, Chen Luo, Lin Pan, Mai Suganami, Mika Chiba, Ryo Yoshimura, Kyoko Yasuda, Keiko Iida, Naomi Ohsumi, Adam Strange, Yuki Shibatani, Tomoko Nishiuchi, Shiho Tanaka, Olivia Putri, Gustav Joas, Yoonjin Kim, Daichi Yamasoba, Kazuhisa Yoshimura, Kenji Sadamasu, Mami Nagashima, Hiroyuki Asakura, Isao Yoshida, So Nakagawa, Akifumi Takaori‐Kondo, Kotaro Shirakawa, Kayoko Nagata, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Yugo Kawai, Takamasa Ueno, Chihiro Motozono, Mako Toyoda, Terumasa Ikeda, Akatsuki Saito, Keita Matsuno, Jumpei Ito, Shinya Tanaka, Kei Sato, Takao Hashiguchi, Kazuo Takayama, Takasuke Fukuhara, Kazuo Takayama, Takasuke Fukuhara - Nature Communications 2024 cited by 89

  17. Cell competition with normal epithelial cells promotes apical extrusion of transformed cells through metabolic changes

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shingo Yoshioka, Junichi Kikuta, Masaru Ishii, Masamichi Imajo, Eisuke Nishida, Yoichiro Fujioka, Yusuke Ohba, Toshiro Sato, Yasuyuki Fujita - Nature Cell Biology 2017 cited by 229

  18. Lewy pathology of the esophagus correlates with the progression of Lewy body disease: a Japanese cohort study of autopsy cases

    Authors: , , , , , , , , , , , , - Acta Neuropathologica 2020 cited by 85

  19. Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shigeru Fujita, Mai Suganami, Mika Chiba, Ryo Yoshimura, So Nakagawa, Jiaqi Wu, Akifumi Takaori‐Kondo, Kotaro Shirakawa, Kayoko Nagata, Yasuhiro Kazuma, Ryosuke Nomura, Yoshihito Horisawa, Yusuke Tashiro, Yugo Kawai, Takao Hashiguchi, Tateki Suzuki, Kanako Kimura, Jiei Sasaki, Yukari Nakajima, Ayaka Sakamoto, Naoko Yasuhara, Takashi Irie, Ryoko Kawabata, Terumasa Ikeda, Hesham Nasser, Ryo Shimizu, Monira Begum, Otowa Takahashi, Kimiko Ichihara, Takamasa Ueno, Chihiro Motozono, Mako Toyoda, Akatsuki Saito, Yuri Tanaka, Erika P. Butlertanaka, Maya Shofa, Kaori Tabata, Isao Yokota, Keita Matsuno, Kazuo Takayama, Shinya Tanaka, Kei Sato, Takasuke Fukuhara - Communications Biology 2023 cited by 64

  20. STAT3 Inhibition Overcomes Temozolomide Resistance in Glioblastoma by Downregulating MGMT Expression

    Authors: , , , , , , , , , - Molecular Cancer Therapeutics 2012 cited by 197

  21. Transgenic expression of Helicobacter pylori CagA induces gastrointestinal and hematopoietic neoplasms in mouse

    Authors: , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 585

  22. The JAK inhibitor tofacitinib regulates synovitis through inhibition of interferon‐γ and interleukin‐17 production by human CD4+ T cells

    Authors: , , , , , , , , , , , - Arthritis & Rheumatism 2011 cited by 231

  23. Tet2 and Tet3 in B cells are required to repress CD86 and prevent autoimmunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature Immunology 2020 cited by 96

  24. Staging of astrocytopathy and complement activation in neuromyelitis optica spectrum disorders

    Authors: , , , , , , , , , , , , , , , , , , , - Brain 2021 cited by 88